Clinical Trial Update: A Trial of Vigil for Participants With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Gradalis' Vigil in ovarian cancer, noting the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Neoplasms

Drugs mentioned

• Vigil

Snippet

Sponsor: Gradalis, Inc. | Conditions: Ovarian Cancer, Ovarian Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING